Related Experiment Video
Updated: Aug 13, 2026
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
Published on: March 17, 2012
[Spinal muscular atrophy. A 4-year prospective, multicenter, longitudinal study (168 cases)]
Annie Barois1, Michèle Mayer, Isabelle Desguerre
1Hôpital Raymond Poincaré - 92380 Garches.
Spinal muscular atrophy (SMA) is a neuromuscular disorder. This study found that motor function, respiratory function, and vital capacity significantly worsen over time in SMA patients, highlighting the need for outcome measures in trials.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Context:
- Spinal muscular atrophy (SMA) is a severe autosomal recessive neuromuscular disease.
- SMA is characterized by progressive motoneuron degeneration.
- Currently, no specific cure exists, emphasizing the importance of supportive care.
Purpose:
- To investigate the natural history of SMA.
- To identify clinical and non-invasive prognostic criteria for SMA.
- To evaluate outcome measures for therapeutic trials in SMA.
Summary:
- A 4-year prospective multicenter study followed 168 SMA patients.
- Muscle strength, motor function (IFM), respiratory function (IMR), and vital capacity (ICV/CT) were assessed.
- All three criteria significantly worsened by approximately 20% over the follow-up period.
Impact:
- The motor function and examination index (IFM) showed significant decline across all age groups and SMA types.
- IFM is proposed as a key outcome measure for future SMA clinical trials.
- Understanding SMA's natural progression is crucial for developing and testing effective treatments.
More Related Videos
09:07Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles
Published on: September 25, 2015
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
